Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Twenty-four base pairs of the human antioxidant response element (hARE) are required for high basal transcription of the NAD(P)H:quinone oxidoreductase 1 (NQO 1 ) gene and its induction in response to xenobiotics and antioxidants. hARE is a unique cis-element that contains one perfect and one imperfect AP1 element arranged as inverse repeats separated by 3 bp, followed by a “GC” box. We report here that Jun, Fos, Fra, and Nrf nuclear transcription factors bind to the hARE. Overexpression of cDNA derived combinations of the nuclear proteins Jun and Fos or Jun and Fra1 repressed hARE-mediated chloramphenicol acetyltransferase (CAT) gene expression in transfected human hepatoblastoma (Hep-G2) cells. Further experiments suggested that this repression was due to overexpression of c-Fos and Fra1, but not due to Jun proteins. The Jun (c-Jun, Jun-B, and Jun-D) proteins in all the possible combinations were more or less ineffective in repression or upregulation of hARE-mediated gene expression. Interestingly, overexpression of Nrf1 and Nrf2 individually in Hep-G2 and monkey kidney (COS1) cells significantly increased CAT gene expression from reporter plasmid hARE-thymidine kinase-CAT in transfected cells that were inducible by β-naphthoflavone and tert -butyl hydroquinone. These results indicated that hARE-mediated expression of the NQO 1 gene and its induction by xenobiotics and antioxidants are mediated by Nrf1 and Nrf2. The hARE-mediated basal expression, however, is repressed by overexpression of c-Fos and Fra1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Affinity purification of sequence-specific DNA binding proteins.
Kadonaga, J. T., & Tjian, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5889 · Cited by 1,154
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
Angel, P., & Karin, M. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90011-9 · Cited by 450
Glutathione S-transferases, structure, regulation, and therapeutic implications
Rushmore, T. H., & Pickett, C. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50219-8 · Cited by 405
REGULATION OF BACTERIAL OXIDATIVE STRESS GENES
Demple, B. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.001531 · Cited by 380
Li, Y., & Jaiswal, A. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42151-5 · Cited by 353
Self-citationCloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast.
Chan, J. Y., Han, X. L., & Kan, Y. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11371 · Cited by 339
DT-diaphorase and cancer chemotherapy
Riley, R. J., & Workman, P. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90694-e · Cited by 283
Jaiswal, A. K. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90272-0 · Cited by 240
Self-citationYoshioka, K., Deng, T., Cavigelli, M., & Karin, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4972 · Cited by 228
Research works printed but not linked: 2
- P Angel, M Karim Biochim Biophys Acta 1072, 129–157 (1991).
- D De Cesare, D Vallone, A Caracciolo, P Sassone-Corsi, C Nerlov, P Verde Oncogene 11, 365–376 (1995).
Cited by
Items 101–167 of 167
IMPACT OF CELLULAR METABOLISM ON THE BIOLOGICAL EFFECTS OF BENZO[A]PYRENE AND RELATED HYDROCARBONS†
Miller, K. P., & Ramos, K. S. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-100000138 · Cited by 332
Sun, Z., Zhang, S., Chan, J. Y., & Zhang, D. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00630-07 · Cited by 332
The Nrf2–Keap1 defence pathway: Role in protection against drug-induced toxicity
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2008) · Toxicology · doi:10.1016/j.tox.2007.10.029 · Cited by 329
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention
Hayes, J. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00695-4 · Cited by 323
Chan, J. Y., & Kwong, M. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00238-4 · Cited by 320
Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S., & Yoshida, T. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2003 · Cited by 317
Redox regulation: mechanisms, biology and therapeutic targets in diseases
Li, B., Ming, H., Qin, S., Nice, E. C., Dong, J., Du, Z., & Huang, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02095-6 · Cited by 317
Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
Ma, Q., & He, X. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004333 · Cited by 317
Kong, A.-N. T., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., & Mandlekar, S. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000652 · Cited by 316
Hemin-induced Activation of the Thioredoxin Gene by Nrf2
Kim, Y.-C., Masutani, H., Yamaguchi, Y., Itoh, K., Yamamoto, M., & Yodoi, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100103200 · Cited by 314
Chemoprevention through the Keap1–Nrf2 signaling pathway by phase 2 enzyme inducers
Kwak, M.-K., Wakabayashi, N., & Kensler, T. W. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.06.041 · Cited by 311
Kwak, M.-K., Itoh, K., Yamamoto, M., Sutter, T. R., & Kensler, T. W. (2001) · Molecular Medicine · doi:10.1007/bf03401947 · Cited by 306
Targeting NRF2 signaling for cancer chemoprevention
Kwak, M.-K., & Kensler, T. W. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.028 · Cited by 305
Keum, Y.-S., Yu, S., Chang, P. P.-J., Yuan, X., Kim, J.-H., Xu, C., Han, J., Agarwal, A., & Kong, A.-N. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3513 · Cited by 303
Leung, L., Kwong, M., Hou, S., Lee, C., & Chan, J. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308439200 · Cited by 302
Gene regulation of heme oxygenase-1 as a therapeutic target
Immenschuh, S., & Ramadori, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00443-3 · Cited by 301
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
David, J. A., Rifkin, W. J., Rabbani, P. S., & Ceradini, D. J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4826724 · Cited by 301
Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues
Siegel, D., & Ross, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00310-5 · Cited by 298
Blais, J. D., Addison, C. L., Edge, R., Falls, T., Zhao, H., Wary, K., Koumenis, C., Harding, H. P., Ron, D., Holcik, M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01145-06 · Cited by 297
The Role of Nrf2 in Cardiovascular Function and Disease
Satta, S., Mahmoud, A. M., Wilkinson, F. L., Yvonne Alexander, M., & White, S. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9237263 · Cited by 293
Dhakshinamoorthy, S., & Jaiswal, A. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204506 · Cited by 293
Self-citationSingh, S., Vrishni, S., Singh, B. K., Rahman, I., & Kakkar, P. (2010) · Free Radical Research · doi:10.3109/10715762.2010.507670 · Cited by 293
Talalay, P., Dinkova-Kostova, A. T., & Holtzclaw, W. D. (2003) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(02)00038-9 · Cited by 289
Pietsch, E. C., Chan, J. Y., Torti, F. M., & Torti, S. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210664200 · Cited by 284
Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease
Aleksunes, L. M., & Manautou, J. E. (2007) · Toxicologic Pathology · doi:10.1080/01926230701311344 · Cited by 285
Pickering, A. M., Linder, R. A., Zhang, H., Forman, H. J., & Davies, K. J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277145 · Cited by 282
Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., & Kong, A.-N. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27545 · Cited by 281
Chan, J. Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1779 · Cited by 281
Gao, L., Wang, J., Sekhar, K. R., Yin, H., Yared, N. F., Schneider, S. N., Sasi, S., Dalton, T. P., Anderson, M. E., Chan, J. Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607622200 · Cited by 277
Kong, A.-N. T., Yu, R., Chen, C., Mandlekar, S., & Primiano, T. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02976458 · Cited by 274
Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.03.003 · Cited by 271
Li, N., Venkatesan, M. I., Miguel, A., Kaplan, R., Gujuluva, C., Alam, J., & Nel, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3393 · Cited by 267
Introducing the “TCDD-Inducible AhR-Nrf2 Gene Battery”
Yeager, R. L., Reisman, S. A., Aleksunes, L. M., & Klaassen, C. D. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp115 · Cited by 266
Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact
Sládek, N. E. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10057 · Cited by 266
Chen, C., Pung, D., Leong, V., Hebbar, V., Shen, G., Nair, S., Li, W., & Tony Kong, A.-N. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.021 · Cited by 260
Amodio, N., Stamato, M. A., Juli, G., Morelli, E., Fulciniti, M., Manzoni, M., Taiana, E., Agnelli, L., Cantafio, M. E. G., Romeo, E., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0067-3 · Cited by 260
Dinkova-Kostova, A. T., & Talalay, P. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00300-2 · Cited by 258
Aleksunes, L. M., & Klaassen, C. D. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045112 · Cited by 257
Moinova, H. R., & Mulcahy, R. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14683 · Cited by 255
Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
Kanninen, K., Malm, T. M., Jyrkkänen, H.-K., Goldsteins, G., Keksa-Goldsteine, V., Tanila, H., Yamamoto, M., Ylä-Herttuala, S., Levonen, A.-L., & Koistinaho, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.010 · Cited by 255
Thirty years of NRF2: advances and therapeutic challenges.
Zhang, D. D. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01145-0 · Cited by 282
Antioxidant and bioenergetic coupling between neurons and astrocytes
Fernandez-Fernandez, S., Almeida, A., & Bolaños, J. P. (2012) · Biochemical Journal · doi:10.1042/bj20111943 · Cited by 247
A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity
Greco, T., Glenn, T. C., Hovda, D. A., & Prins, M. L. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15610584 · Cited by 210
Redox signaling: an evolution from free radicals to aging
Forman, H. J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.003 · Cited by 172
Ebselen, a Glutathione Peroxidase Mimetic Seleno-organic Compound, as a Multifunctional Antioxidant
Nakamura, Y., Feng, Q., Kumagai, T., Torikai, K., Ohigashi, H., Osawa, T., Noguchi, N., Niki, E., & Uchida, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109641200 · Cited by 161
Ooi, A., Dykema, K., Ansari, A., Petillo, D., Snider, J., Kahnoski, R., Anema, J., Craig, D., Carpten, J., Teh, B.-T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3227 · Cited by 159
Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells
Um, H.-C., Jang, J.-H., Kim, D.-H., Lee, C., & Surh, Y.-J. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.06.001 · Cited by 153
Kang, C.-H., Choi, Y. H., Moon, S.-K., Kim, W.-J., & Kim, G.-Y. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.09.009 · Cited by 138
Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer’s disease
Raina, A. K., Templeton, D. J., deak, J. C., Perry, G., & Smith, M. A. (1999) · Redox Report · doi:10.1179/135100099101534701 · Cited by 120
Nrf2 promotes survival following exposure to ionizing radiation
Sekhar, K. R., & Freeman, M. L. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.035 · Cited by 109
“Nrf2 heterodimerization with MAF-G [20] or the JUN CnC-bZIP factor [21] licenses binding to cis antioxidant response elements (AREs) located in proximal promoters of Nrf2 target genes that now number over 500 [20], including those involved in carbohydrate and lipid metabolism, NADPH regeneration, heme and iron metabol…”
BackgroundGalea, E., Launay, N., Portero-Otin, M., Ruiz, M., Pamplona, R., Aubourg, P., Ferrer, I., & Pujol, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.005 · Cited by 108
Complexity of CNC Transcription Factors As Revealed by Gene Targeting of the Nrf3 Locus
Derjuga, A., Gourley, T. S., Holm, T. M., Heng, H. H. Q., Shivdasani, R. A., Ahmed, R., Andrews, N. C., & Blank, V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3286-3294.2004 · Cited by 100
Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species
Imhoff, B. R., & Hansen, J. M. (2009) · Biochemical Journal · doi:10.1042/bj20091286 · Cited by 92
Aspera-Werz, R. H., Ehnert, S., Heid, D., Zhu, S., Chen, T., Braun, B., Sreekumar, V., Arnscheidt, C., & Nussler, A. K. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3172480 · Cited by 90
Petrick, J. S., & Klaassen, C. D. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015974 · Cited by 85
“Nrf2 is thought to regulate expression of a battery of antioxidant genes including its classic target gene Nqo1 (Venugopal and Jaiswal, 1996), Gsts, and the glutamate cysteine ligase catalytic and modifier subunits (McMahon et al., 2001).”
Nrf2-mediated redox signaling in arsenic carcinogenesis: a review
Sinha, D., Biswas, J., & Bishayee, A. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0920-5 · Cited by 81
Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer
Jeddi, F., Soozangar, N., Sadeghi, M. R., Somi, M. H., Shirmohamadi, M., Eftekhar-Sadat, A.-T., & Samadi, N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.129 · Cited by 75
Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury
Cole, M. P., Rudolph, T. K., Khoo, N. K. H., Motanya, U. N., Golin-Bisello, F., Wertz, J. W., Schopfer, F. J., Rudolph, V., Woodcock, S. R., Bolisetty, S., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.199075 · Cited by 69
TANAKA, Y., ALEKSUNES, L., GOEDKEN, M., CHEN, C., REISMAN, S., MANAUTOU, J., & KLAASSEN, C. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.05.022 · Cited by 60
Iwasaki, K., Hailemariam, K., & Tsuji, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701477200 · Cited by 41
Froyen, E. B., & Steinberg, F. M. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.008 · Cited by 34
“Expression of phase II enzymes is regulated in part through activation and translocation of the redox-sensitive transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) into the nucleus where it forms a heterodimer with other transcription factors and binds to the antioxidant response element (ARE) of g…”
BackgroundBarreiro, E., Puig-Vilanova, E., Salazar-Degracia, A., Pascual-Guardia, S., Casadevall, C., & Gea, J. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00798.2017 · Cited by 30
Liu, J., Aylor, K. W., & Liu, Z. (2023) · Diabetes · doi:10.2337/db22-0745 · Cited by 30
Jin, X., Gong, L., Peng, Y., Li, L., & Liu, G. (2021) · Aging · doi:10.18632/aging.202137 · Cited by 24
“In response to reactive oxygen species (ROS) and other electrophiles, Nrf2 activates gene transcription of a set of drugmetabolizing enzymes, such as glutathione S-transferase (GST) and NAD(P)H: quinone oxidoreductase 1 (NQO1) [30, 31].”
Yue, X., Acun, A., & Zorlutuna, P. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.06.031 · Cited by 16
Metadata
- Authors
- Venugopal, R., & Jaiswal, A. K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-12-10
- Volume
- 93
- Issue
- 25
- Pages
- 14960-14965
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1971090593
- Cited by
- 1,040
- References
- 19
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.